Literature DB >> 17683016

Clinical management of Clostridium difficile-associated disease.

Mark A Miller1.   

Abstract

The incidence of Clostridium difficile-associated disease (CDAD) and its serious complications (including colectomy and death) have been increasing worldwide. This phenomenon is strongly associated with the appearance of a new "hypervirulent" strain in several countries. More-effective strategies are needed for the prevention and treatment of this entity. This article will review the current approaches using antimicrobials, probiotics, immunomodulation, surgery, and miscellaneous adjuvants to prevent and treat this infection.

Entities:  

Mesh：

Year:  2007        PMID： 17683016     DOI： 10.1086/519257

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  15 in total

Review 1.  Review of medical and surgical management of Clostridium difficile infection.

Authors:  B Faris; A Blackmore; N Haboubi
Journal:  Tech Coloproctol       Date:  2010-05-08       Impact factor: 3.781

Review 2.  Clinical update for the diagnosis and treatment of Clostridium difficile infection.

Authors:  Edward C Oldfield; Edward C Oldfield; David A Johnson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

3.  Association between Do Not Resuscitate/Do Not Intubate Status and Resident Physician Decision-making. A National Survey.

Authors:  Elizabeth K Stevenson; Hashim M Mehter; Allan J Walkey; Renda Soylemez Wiener
Journal:  Ann Am Thorac Soc       Date:  2017-04

Review 4.  Clostridium difficile infection in the intensive care unit.

Authors:  David J Riddle; Erik R Dubberke
Journal:  Infect Dis Clin North Am       Date:  2009-09       Impact factor: 5.982

5.  Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship.

Authors:  Udayakumar Navaneethan; Preethi Gk Venkatesh; Bo Shen
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

6.  Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein.

Authors:  Christian Hardt; Thomas Berns; Wolfgang Treder; Franz-Ludwig Dumoulin
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

7.  Clostridium difficile-associated enteric disease after percutaneous endoscopic gastrostomy.

Authors:  Shiro Yokohama; Masaru Aoshima; Toshiyuki Asama; Junya Shindo; Junichi Maruyama
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

Review 8.  Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea.

Authors:  V K Viswanathan; Kim Hodges; Gail Hecht
Journal:  Nat Rev Microbiol       Date:  2008-12-31       Impact factor: 60.633

9.  Identification of risk factors for the development of clostridium difficile-associated diarrhea following treatment of polymicrobial surgical infections.

Authors:  Rosemarie Metzger; Brian R Swenson; Hugo Bonatti; Traci L Hedrick; Tjasa Hranjec; Kimberley A Popovsky; Timothy L Pruett; Robert G Sawyer
Journal:  Ann Surg       Date:  2010-04       Impact factor: 12.969

10.  Emerging Insights into Antibiotic-Associated Diarrhea and Clostridium difficile Infection through the Lens of Microbial Ecology.

Authors:  Seth T Walk; Vincent B Young
Journal:  Interdiscip Perspect Infect Dis       Date:  2008-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.